Aubert, Carole E; Gencer, Baris; Rodondi, Nicolas (2016). [Recommendations for management of dyslipidemia in 2016 in Switzerland]. Revue médicale suisse, 12(508), pp. 430-434. Médecine & Hygiène
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Aubert RevMedSuisse 2016.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (2MB) |
Discordance between American guidelines and the "Swiss medical Board" position regarding treatment of dyslipidemia raised many questions. While benefits of statins are clear in secondary prevention, care should be individualised according to PROCAM cardiovascular risk score adapted to Switzerland in primary prevention. Lifestyle modification should be the first line therapy and a drug therapy is an option in high or intermediate risk, but not anymore in low cardiovascular risk. Familial dyslipidemia, often identified only after first cardiovascular event, should not be missed, as particular care is needed and riskscores cannot be used in this situation. Statins adverse effects remain a challenge in daily clinical practice.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine 04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine |
UniBE Contributor: |
Aubert, Carole Elodie, Rodondi, Nicolas |
Subjects: |
600 Technology > 610 Medicine & health 300 Social sciences, sociology & anthropology > 360 Social problems & social services |
ISSN: |
0025-6749 |
Publisher: |
Médecine & Hygiène |
Language: |
French |
Submitter: |
Doris Kopp Heim |
Date Deposited: |
10 Jan 2017 11:09 |
Last Modified: |
05 Dec 2022 15:01 |
PubMed ID: |
27089598 |
BORIS DOI: |
10.7892/boris.92324 |
URI: |
https://boris.unibe.ch/id/eprint/92324 |
Actions (login required)
 |
Edit item |